ESR2 and prostate cancer: GATA2, 3-fold overexpressed after ESR2 knockdown in HEC-1A cells, is a transcription factor, which has been reported to be overexpressed in non-familial EVI1-positive acute myeloid leukemia as well as in prostate cancer.